Loading...
Market
Primary distribution channel of saliva test by June 2024?
4
Resolution / Starting Odds
Pharmacies • 33%
Online Retailers • 33%
Direct from Manufacturer • 33%
Sales and distribution data from the manufacturing company
Story
New At-Home Saliva Test for Prostate Cancer Analyzing DNA Markers Could Save Thousands of Lives
May 31, 2024, 11:07 PM
Scientists have developed a new at-home saliva test for prostate cancer that promises to revolutionize detection and treatment. The test, which analyzes DNA markers in saliva to determine genetic risk, could save thousands of lives and significantly reduce healthcare costs. This advancement is particularly beneficial for individuals with limited, low-grade, slow-growing prostate cancer who wish to delay surgery or radiation due to concerns about side effects. The test, praised for its affordability and quick results, is expected to enable widespread screening, especially among middle-aged men, potentially turning the tide on prostate cancer. The development has been highlighted by the Daily Express and is based on a landmark study, showcasing the power of domestic diagnostics.
View original story
Similar markets
Below 10% • 25%
10% to 30% • 25%
30% to 50% • 25%
Above 50% • 25%
Below 25% • 25%
25% to 50% • 25%
50% to 75% • 25%
Above 75% • 25%
High in urban areas • 25%
High in rural areas • 25%
Uniform across regions • 25%
Low overall adoption • 25%
No competitors respond • 25%
1-2 competitors respond • 25%
3-5 competitors respond • 25%
More than 5 competitors respond • 25%
Increase by over 50% • 25%
Increase by 20-50% • 25%
Increase by less than 20% • 25%
Decrease • 25%